Published on Tuesday March 05, 2024

Smooth Drug Development February 2024 News Release

We are working on the following new projects:

  • A contract for a phase III study with Aflibercept was signed.
  • We are signing contracts for medical writing services for BE trials with Rabeprazole, for a phase II trial with Cetirizin and a phase III trial with Benzalkonium chloride + Lidocaine with our long-term Indian client.

We are happy to reach the following milestones in our projects:

  • 18 patients were randomized in a phase III clinical trial in paroxysmal nocturnal hemoglobinuria.
  • Monitoring visits were performed in Uzbekistan in the observational program of multivitamins in pregnant and childbearing women.
  • Start-up was performed in an Ezetimibe trial.